Dentsply Sirona Reports Preliminary Fourth Quarter and Full Year 2017 Results

Medical Device Investing

DENTSPLY SIRONA (Nasdaq:XRAY), The Dental Solutions Company, today announced its preliminary financial results for the three and twelve months ended December 31, 2017. As quoted in the press release: Net loss attributable to Dentsply Sirona for the fourth quarter of 2017 was $673.4 million, or a loss of $2.95 per diluted share, compared to net …

DENTSPLY SIRONA (Nasdaq:XRAY), The Dental Solutions Company, today announced its preliminary financial results for the three and twelve months ended December 31, 2017.

As quoted in the press release:

Net loss attributable to Dentsply Sirona for the fourth quarter of 2017 was $673.4 million, or a loss of $2.95 per diluted share, compared to net income of $107.0 million, or $0.46 per diluted share in the fourth quarter of 2016.  GAAP loss included a non-cash goodwill impairment charge of $581.0 million and an indefinite-lived intangible asset impairment charge of $266.9 million both driven by management’s projections, tax reform and foreign exchange rate changes. On an adjusted basis, excluding certain items, non-GAAP net earnings per diluted share were $0.82 compared to $0.67 in the fourth quarter of 2016.  A reconciliation of the non-GAAP measures to earnings per share calculated on a US-GAAP basis is provided in the attached tables.

Click here to read the full press release.

The Conversation (0)
Ă—